References
- Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis. Circulation 1997;96:1445–53.
- Weitz J. Antithrombotic drugs. Hematology basic principles and practice5th, R Hoffman, E Benz, S Shattil. Elsevier, Philadelphia 2009; 2070
- Pedersen BU, Andersen M, Hansen PB. Drug induced thrombocytopenia: Clinical data on 309 cases and the effect of corticosteroid therapy. Eur J Clin Pharmacol 1997; 52: 183–189
- Bougie DW, Wilker PR, Wuitschick ED, Curtis BR, Malik M, Levine S, Lind RN, Pereira J, Aster RH. Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GpIIb/IIIa. Blood 2002; 100: 2071–2076
- Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 2001; 344: 1286–1292
- Sanchez GC, Harizi H, Nurden A, Coste P, Jais C, Nurden P. A case of profound and prolonged tirofiban-induced thrombocytopenia and its correction by intravenous immunglobulin G. International society on thrombosis and haemostasis. J Thromb Haemost 2007; 5: 1068–1070
- Panduranga P, Sulaiman K. Severe thrombocytopenia following tirofiban infusion. Indian J Pharmacol 2011; 43: 726–728
- Sakellariou D, Pastromas S, Koulouris S, Manolis A. First report of tirofiban-induced anemia. Tex Heart Inst J 2009; 36: 55–57